Will IRP upend Czech orphan drug reforms?
Click here to access GlobalData’s Market Access and Pricing Services
ByPharma Price Benchmarks & Indexes
Variations on an IRP theme: How payers are repurposing pricing policies for new categories of medicines
Click here to access GlobalData’s Market Access and Pricing Services
By
California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs
Click here to access GlobalData’s Market Access and Pricing Services
By
Why are pharma prices changing?
Click here to access GlobalData’s Market Access and Pricing Services
By